10.17USD
845.04 MUSD
3.66 BUSD
82.27 M
About IDEXX Laboratories, Inc.
Sector
Industry
CEO
Jonathan J. Mazelsky
Website
Headquarters
Westbrook
Employees (FY)
11 K
Founded
1983
ISIN
US45168D1046
FIGI
BBG000BLRT07
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IDXX is 477.79 USD — it has decreased by 0.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IDEXX Laboratories, Inc. stocks are traded under the ticker IDXX.
IDEXX Laboratories, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
IDXX stock is 1.59% volatile and has beta coefficient of 1.79. Check out the list of the most volatile stocks — is IDEXX Laboratories, Inc. there?
One year price forecast for IDEXX Laboratories, Inc. has a max estimate of 675.00 USD and a min estimate of 570.00 USD.
IDXX earnings for the last quarter are 2.53 USD whereas the estimation was 2.37 USD which accounts for 6.72% surprise. Estimated earnings for the next quarter are 2.12 USD. See more details about IDEXX Laboratories, Inc. earnings.
IDEXX Laboratories, Inc. revenue for the last quarter amounts to 915.53 M USD despite the estimated figure of 926.88 M USD. In the next quarter revenue is expected to reach 891.88 M USD.
Yes, you can track IDEXX Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
IDXX stock has fallen by 5.23% compared to the previous week, the month change is a 9.70% fall, over the last year IDEXX Laboratories, Inc. has showed a 0.67% decrease.
IDXX net income for the last quarter is 194.52 M USD, while the quarter before that showed 212.23 M USD of net income which accounts for −8.34% change. Track more IDEXX Laboratories, Inc. financial stats to get the full picture.
Today IDEXX Laboratories, Inc. has the market capitalization of 39.74 B, it has decreased by 1.34% over the last week.
No, IDXX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IDXX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 11.00 K employees. See our rating of the largest employees — is IDEXX Laboratories, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IDEXX Laboratories, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IDEXX Laboratories, Inc. stock shows the buy signal. See more of IDEXX Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IDEXX Laboratories, Inc. future price: according to them, IDXX price has a max estimate of 675.00 USD and a min estimate of 570.00 USD. Read a more detailed IDEXX Laboratories, Inc. forecast: see what analysts think of IDEXX Laboratories, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IDEXX Laboratories, Inc. EBITDA is 1.21 B USD, and current EBITDA margin is 32.98%. See more stats in IDEXX Laboratories, Inc. financial statements.